Publication Author: Ezekowitz JA
Filter by Author:
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure.
Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Piña IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J.
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis.
Tang WHW, Liu Y, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Marwick TH, Perfetti R, Rosenstock J, Solomon SD, Zannad F, Januzzi JL, Lewis GD.
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial.
Ezekowitz JA, Mulder H, Mentz RJ, Butler J, De Pasquale CG, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Numan S, Blackman N, Rockhold FW, Hernandez AF.
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.
Ufnal M, Connolly K, Millegard M, Surkova E, Guazzi M, Bonderman D, Ezekowitz J, Gustafsson F, Ciurzyński M, Vilella RL, Ahmad T, Gardner R, Jansa P, van Wijk S, Kinugawa K, Björklund E, Jing ZC, Rosenkranz S.
Diuretic Potentiation Strategies in Acute Heart Failure.
Siddiqi TJ, Packer M, Ezekowitz JA, Fonarow GC, Greene SJ, Kittleson M, Khan MS, Mentz RJ, Testani J, Voors AA, Butler J.
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial.
Marwick TH, Lam C, Liu Y, Del Prato S, Rosenstock J, Butler J, Ezekowitz J, Ibrahim NE, Tang WHW, Zannad F, Perfetti R, Januzzi JL.
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.
Weir MR, Rossignol P, Pitt B, Lund LH, Coats AJS, Filippatos G, Perrin A, Waechter S, Budden J, Kosiborod M, Metra M, Boehm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Castro-Montes E, Nicolau JC, Parkhomenko A, Seferovic P, Cohen-Solal A, Anker SD, Butler J.
The Relationship of Diuretics and Dietary Sodium in Patients with Heart Failure: An Analysis of the SODIUM-HF Trial
Zhou K, Alemayehu W, Rathwell S, McAlister FA, Ross H, Escobedo J, Saldarriaga C, Colin-Ramirez E, Macdonald P, Arcand J, Troughton R, Ezekowitz JA; SODIUM-HF Investigators.
The “small” clinical trial: Methods, analysis and interpretation in acute care cardiology.
Zampieri FG, Ezekowitz JA.
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial.
Reddy YNV, Butler J, Anstrom KJ, Blaustein RO, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor C, Patel M, Ponikowski P, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F.
Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial.
Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, Ponikowski P, Voors A, Corda S, McMullan C, O'Connor CM, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia.
Pitt B, Anker SD, Lund LH, Coats AJS, Filippatos G, Rossignol P, Weir MR, Friede T, Kosiborod MN, Metra M, Böhm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Piña IL, Pinto FJ, van der Meer P, Bahit C, Belohlavek J, Brugts JJ, Perrin A, Waechter S, Budden J, Butler J.
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis.
Coats AJS, Anker SD, Lund LH, Filippatos G, Rossignol P, Pitt B, Weir MR, Kosiborod MN, Metra M, Böhm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Cleland JGF, Goudev A, Khintibidze I, Lindenfeld J, Merkely B, Waechter S, Budden J, Perrin A, Butler J.
Comparing Analytical Methods for Composite Endpoints in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) Trial.
Westerhout CM, Rathwell S, Anstrom KJ, Hernandez AF, Ponikowski P, Ezekowitz JA, Voors AA, Felker GM, Bakal JA, Blaustein RO, Nkulikiyinka R, O'Connor CM, Armstrong PW; VICTORIA Study Group.
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.
Weir MR, Rossignol P, Pitt B, Lund LH, Coats AJS, Filippatos G, Perrin A, Waechter S, Budden J, Kosiborod M, Metra M, Boehm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Castro-Montes E, Nicolau JC, Parkhomenko A, Seferovic P, Cohen-Solal A, Anker SD, Butler J.
Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19.
Paterson DI, White JA, Beaulieu C, Sherrington R, Prado CM, Tandon P, Halloran K, Smith S, McCombe JA, Ritchie B, Pituskin E, Haykowsky MJ, Coulden R, Emery D, Tsui AK, Wu KY, Oudit GY, Ezekowitz JA, Thompson RB.
eMPower: An online Mind-body wellness Program for adults living with chronic health conditions: A three-armed randomized controlled trial protocol.
Johnson E, Ismond K, Hyde A, Ezekowitz J, Wright G, Spiers J, Spence J, Thompson S, McNeely ML, Zheng Y, Round J, Tymchuk S, Lee-Baggley D, Isley S, Corrick S, Minckler H, Tandon P.
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy.
Gouda P, Liu Y, Butler J, Del Prato S, Ibrahim NE, Lam CSP, Marwick T, Rosenstock J, Tang W, Zannad F, Januzzi J, Ezekowitz J.
Rethinking Composite Endpoints with the Win Ratio: A Breakthrough or Business as Usual?
Grubic N, Ezekowitz JA.
Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
Collister D, Pyne L, Bhasin AA, Smyth B, Herrington W, Jardine M, Mark PB, Badve S, Rossignol P, Dember LM, Wanner C, Ezekowitz J, Devereaux PJ, Parfrey P, Gansevoort R, Walsh M.
